Effects of lovastatin on expression of cell cycle regulatory proteins in vascular smooth muscle cells

Kidney International, Supplement

Volumn 56, Issue 71, 1999, Pages

  Oda, Hiroaki ^a   Kasiske, Bertram L ^a   O'Donnell, Michael P ^a,b   Keane, William F ^a  

^a HENNEPIN COUNTY MEDICAL CENTER   (United States)

^b MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

CDK2; CDK4; Cyclin D1; Cyclin E; DNA synthesis

Indexed keywords

CDK2 PROTEIN, RAT; CDK4 PROTEIN, RAT; CDKN1B PROTEIN, RAT; CELL CYCLE PROTEIN; CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN E; DNA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; MICROTUBULE ASSOCIATED PROTEIN; ONCOPROTEIN; PLATELET DERIVED GROWTH FACTOR; PROTEIN SERINE THREONINE KINASE; TUMOR SUPPRESSOR PROTEIN; CYCLIN D; PLATELET DERIVED GROWTH FACTOR BB;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; DRUG EFFECT; METABOLISM; RAT; VASCULAR SMOOTH MUSCLE; ANIMAL CELL; ARTERY INTIMA PROLIFERATION; CONFERENCE PAPER; DNA SYNTHESIS INHIBITION; LIPID METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

ANIMALS; CDC2-CDC28 KINASES; CELL CYCLE PROTEINS; CELLS, CULTURED; CYCLIN D1; CYCLIN E; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; DNA; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOVASTATIN; MICROTUBULE-ASSOCIATED PROTEINS; MUSCLE, SMOOTH, VASCULAR; PLATELET-DERIVED GROWTH FACTOR; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; RATS; TUMOR SUPPRESSOR PROTEINS;

EID: 0033007719     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. GERAGHTY JG, STOLTENBERG RL, SOLLINGER HW, HULLETT DA: Vascular smooth muscle cells and neointimal hyperplasia in chronic transplant rejection. Transplantation 62:502-509, 1996
2. MYLLARNIEMI M, CALDERON L, LEMSTROM K, BUCHDUNGER E, HAYRY P: Inhibition of platelet-derived growth factor receptor tyrosine kinase inhibits vascular smooth muscle cell migration and proliferation. FASEB J 11:1119-1126, 1997
3. POMERANTZ KB, LANDER HM, SUMMERS B, ROBISHAW JD, BALCUEVA E, HAJJAR DP: G-protein-mediated signaling in cholesterol-enriched arterial smooth muscle cells. I. Reduced membrane-associated G-protein content due to diminished isoprenylation of G-gamma subunits and p21ras. Biochemistry 36:9523-9531, 1997
4. NEGRE-AMINOU P, VAN ERCK M, VAN THIEL GC, VAN LEEUWEN RE, COHEN LH: Inhibition of proliferation of human smooth muscle cells by various HMG-CoA reductase inhibitors: Comparison with other human cell types. Biochim Biophys Acta 1345:259-268, 1997
5. PARDEE AB: G1 events and regulation of cell proliferation. Science 246:603-608, 1989
6. SHERR CJ: G1 phase progression: Cycling on cue. Cell 79:551-555, 1994
7. MORGAN DO: Principles of CDK regulation. Nature 374:131-134, 1995
8. SHERR CJ, ROBERTS JM: Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9:1149-1163, 1995
9. OHTSUBO M, THEODORAS AM, SCHUMACHER J, ROBERTS JM, PAGANO M: Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol Cell Biol 15:2612-2624, 1995
10. WEINBERG RA: The retinoblastoma protein and the cell cycle. Cell 81:323-330, 1995
11. ARITA Y, BUFFOLINO P, COPPOCK DL: Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity. Exp Cell Res 242:381-390, 1998